About Incisive Health
Brussels Office Since2016
Incisive Health is an award-winning healthcare policy and communications consultancy. We deliver the results that matter for our clients and – ultimately – for the patients they serve. In Brussels, we specialise on EU healthcare policy and communications. Our team advises pharmaceutical and medical technology clients active in the fields of vaccines, rare diseases, oncology, and cardiovascular. As part of the Ashfield Health group, we have access to a global network of healthcare experts, spanning across healthcare marketing, communications, PR, market access and policy. Our team of multilingual and multinational healthcare experts knows how to cut through the noise to deliver real change, and as health specialists, we understand the detail but can see the big picture. With healthcare policy now front and centre in the EU, you can count on us to change minds, mobilise advocates and deliver results.
An Ashfield Health Company, part of UDG Healthcare PLC.
Incisive Health is part of Ashfield Health, a new healthcare marketing and communications network built for today where a global mindset meets individual depth and specialism. Together with our family of agencies, we create life-changing solutions that achieve new realities for our clients.
Our services range from market access communications and strategy development through to media campaigns and clinical advocacy, all underpinned by a deep understanding of EU health policy developments. Every client’s problem is unique, so the programmes we create are tailored to deliver on their ambitions. Our team’s experience and expertise, ranging from vaccines to rare diseases and oncology, and from pharmaceutical to medical technology, allow us to focus on the interventions that will make the difference. We have developed a series of methodologies which create the firm foundations for creative strategies, impactful programmes and exceptional results.
Number of Public Affairs Consultants15 in Brussels and 45 in London
Astellas, Biogen, Edwards Lifesciences, European Brain Council (EBC), European Federation of Pharmaceutical Industries and Associations (EFPIA), Global Blood Therapeutics (GBT), Illumina, MedTech Europe, MSD, Norgine, Roche, Sobi, Stryker and Takeda, amongst others.
At Incisive Health, we pride ourselves on our insights and are not afraid to give our opinion. Our team is passionate about what they do: interrogating the latest policy developments and understanding what they mean for patients. This is underpinned by our values: expert, challenging, exceptional, collaborative, and ambitious.